Veterinary Medicines

HyperCard 10 mg Coated Tablets for Cats

Suspended
  • Diltiazem hydrochloride
Download as PDF

Product identification

Medicine name:
HyperCard 10 mg Coated Tablets for Cats
HYPERCARD
Active substance:
  • Diltiazem hydrochloride
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Diltiazem hydrochloride
    10.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC08DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Suspended
Authorised in:
  • France
Package description:
  • Tablets are located in a preformed low density polyethylene base containing 10 tablets and sealed with PC 100 laminate comprising of low density polyethylene and aluminium foil. Once sealed, 3 blisters of 10 tablets (30 tablets) are placed in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dales Pharmaceuticals Limited
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/8810679 1/2004
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0506/001
Concerned member states:
  • France
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
French (PDF)
Published on: 4/04/2022
Download